Combination of Fenretinide and Selenite Inhibits Proliferation and Induces Apoptosis in Ovarian Cancer Cells

• Main Authors: Xiao-Yan Xin, Jia Li, Jie Liu, Jian-Fang Zhang
• Format: Article
• Language: English
• Published: MDPI AG 2013-11-01
• Series: International Journal of Molecular Sciences
• Subjects: ovarian cancers cell; fenretinide; selenite; combination; anti-tumor effect
• Online Access: http://www.mdpi.com/1422-0067/14/11/21790

The combination of fenretinide and selenite on ovarian cancer cells was investigated to assess its effects on proliferation and ability to induce apoptosis. Our results showed that fenretinide and selenite in combination significantly suppress the proliferation of ovarian cancer cells and induced apoptosis (including reactive oxygen species generation, and the loss of mitochondrial membrane potential) compared with either drug used alone. The caspase3/9-dependent pathway was triggered significantly in combination treatment, and moreover, the AMPK pathway also mediated the apoptosis induction in fenretinide and selenite combination. Fenretinide and selenite combination treatment was demonstrated to suppress tumor growth in vivo, this drug combination has been thus found to have an enhanced anti-tumor effect on ovarian cancers cells.